Sébastien Van de Velde

Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae

Indran Balakrishnan, Fatih M. Awad-El-Kariem, Adnan Aali et al. · Journal of Antimicrobial Chemotherapy · 2011 · 107 citations · Full text

Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration

Pierre-François Laterre, Xavier Wittebole, Sébastien Van de Velde et al. · Journal of Antimicrobial Chemotherapy · 2014 · 85 citations · Full text

Impairment of Growth of<i>Listeria monocytogenes</i>in THP‐1 Macrophages by Granulocyte Macrophage Colony‐Stimulating Factor: Release of Tumor Necrosis Factor–α and Nitric Oxide

Stéphane Carryn, Sébastien Van de Velde, Françoise Van Bambeke et al. · The Journal of Infectious Diseases · 2004 · 25 citations · Full text

Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit

Hani Habayeb, B. Sajin, Keval Patel et al. · European Journal of Clinical Microbiology & Infectious Diseases · 2015 · 22 citations · Full text

Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes

Sébastien Van de Velde, Hoang Anh Nguyen, Françoise Van Bambeke et al. · Journal of Antimicrobial Chemotherapy · 2008 · 19 citations